"This bipartisan legislation will eliminate the pill penalty and help ensure science and researchers – not government bureaucrats – determine the possible treatments innovator companies pursue," said BIO CEO and president John Crowley.
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
TGA approves first-of-a-kind medicine for early symptomatic Alzheimer’s disease
May 21, 2025 - - Latest News -
Examples are important as evidence of the problem, but be prepared to defend them
May 21, 2025 - - Latest News -
Trump administration invites companies to 'align' US pricing under MFN plan
May 21, 2025 - - Latest News -
NDIS minister restates the importance of 'nothing about us, without us!'
May 20, 2025 - - Latest News -
Industry alarm over the sudden pursuit of surprise uncertified claims
May 20, 2025 - - Latest News -
Medicines Australia sharpens post-election language on reform
May 20, 2025 - - Latest News -
Report highlights international confidence in Australian clinical trials
May 19, 2025 - - Latest News